Controlling the pharma machine: EMA conveys thoughts on AI use in industry

Amid rising levels of artificial intelligence (AI) use and application, the European Medicines Agency (EMA) has issued a draft paper outlining its view on the use of AI and machine learning (ML) in various stages of a medicine’s life cycle.